| VIR Snapshot | |
|---|---|
| Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. The company is headquartered in San Francisco, California. | |
| VALUATION DATA | |
| Market Capitalization | $2,025 | Price to Sales | 4.00 |
| Earnings per Share | $0.0000 |
| PE Ratio | -554707968 |
| PRICE DATA | |
| Most Recent Close | $5.1300 |
| 52 Week High | $4.361 |
| 52 Week Low | $37.51 |
| 50-Day Moving Average | $0.752 |
| 200-Day Moving Average | $14.51 |
| All data are from Alpha Vantage as of today. For more infomation on VIR see Stock Dividend, Valuation, Price and Financial Data for Investors | |
Custom Search